Biophysical investigation of interactions between SARS‐CoV ‐2 spike protein and neuropilin‐1
Protein Science · 2023
DOI: 10.1002/pro.4773 ↗At a glance
Journal article in Protein Science, 2023. Written by Decheng Hou and 6 co-authors. Institution: Department of Bioengineering, Lehigh University, Bethlehem, Pennsylvania, USA. Major MEDLINE topics: COVID-19, Neuropilin-1, SARS-CoV-2, Spike Glycoprotein, Coronavirus. Cited 13 times so far (Crossref); 70 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (original language)
Recent studies have suggested that neuropilin‐1 (NRP1) may serve as a potential receptor in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. However, the biophysical characteristics of interactions between NRP1 and SARS‐CoV‐2 remain unclear. In this study, we examined the interactions between NRP1 and various SARS‐CoV‐2 spike (S) fragments, including the receptor‐binding domain (RBD) and the S protein trimer in a soluble form or expressed on pseudovirions, using atomic force microscopy and structural modeling. Our measurements shows that NRP1 interacts with the RBD and trimer at a higher binding frequency (BF) compared to ACE2. This NRP1‐RBD interaction has also been predicted and simulated via AlphaFold2 and molecular dynamics simulations, and the results indicate that their binding patterns are very similar to RBD‐ACE2 interactions. Additionally, under similar loading rates, the most probable unbinding forces between NRP1 and S trimer (both soluble form and on pseudovirions) are larger than the forces between NRP1 and RBD and between trimer and ACE2. Further analysis indicates that NRP1 has a stronger binding affinity to the SARS‐CoV‐2 S trimer with a dissociation rate of 0.87 s −1 , four times lower than the dissociation rate of 3.65 s −1 between NRP1 and RBD. Moreover, additional experiments show that RBD‐neutralizing antibodies can significantly reduce the BF for both ACE2 and NRP1. Together, the study suggests that NRP1 can be an alternative receptor for SARS‐CoV‐2 attachment to human cells, and the neutralizing antibodies targeting SARS‐CoV‐2 RBD can reduce the binding between SARS‐CoV‐2 and NRP1.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Bioengineering, Lehigh University, Bethlehem, Pennsylvania, USA.
- Department of Biomedical Engineering, University of Massachusetts Amherst, Amherst, Massachusetts, USA.
- Departments of Biological Sciences, Chemistry, and Computer Science and Engineering, Lehigh University, Bethlehem, USA.
ORCID profiles: Decheng Hou, Seonghan Kim, Wonpil Im, X Frank Zhang
Funding
- NIAID NIH HHS
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
- Lehigh University
Cite
APA
Hou, D., Cao, W., Kim, S., Cui, X., Ziarnik, M., Im, W., & Zhang, X. F. (2023). Biophysical investigation of interactions between SARS‐CoV ‐2 spike protein and neuropilin‐1. Protein Science. https://doi.org/10.1002/pro.4773
Vancouver
Hou D, Cao W, Kim S, Cui X, Ziarnik M, Im W, et al. Biophysical investigation of interactions between SARS‐CoV ‐2 spike protein and neuropilin‐1. Protein Science. 2023. doi:10.1002/pro.4773
BibTeX
@article{Hou2023,
author = {Hou, Decheng and Cao, Wenpeng and Kim, Seonghan and Cui, Xinyu and Ziarnik, Matthew and Im, Wonpil and Zhang, X Frank},
title = {Biophysical investigation of interactions between SARS‐CoV ‐2 spike protein and neuropilin‐1},
journal = {Protein Science},
year = {2023},
doi = {10.1002/pro.4773}
}
EUVIMED